Skip to main content
Mark Applebaum, MD, Pediatric Hematology & Oncology, Chicago, IL

Mark Applebaum MD

Pediatric Hematology & Oncology•Chicago, IL

Assistant Professor

Join to view full profile

  • 5841 S. MARYLAND AVENUEM/C 4060Chicago, IL 60637

  • Phone+1 773-702-6808

  • Fax+1 773-834-1329

Dr. Applebaum is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Applebaum's full profileAlready have an account?

Education & Training

  • University of Chicago
    University of ChicagoFellowship, Pediatric Hematology/Oncology, 2012 - 2015
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 2008 - 2011
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2008
  • University of California Division of Agriculture and Natural Resources
    University of California Division of Agriculture and Natural ResourcesB.A., Molecular and Cell Biology, 2000 - 2004

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2009 - Present
  • IL State Medical License
    IL State Medical License 2011 - 2029
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Hematology-Oncology
    American Board of Pediatrics Pediatric Hematology-Oncology
  • Board Certification
    American Board of Clinical PharmacologyBoard Certification

Awards, Honors, & Recognition

  • Top 40 Under 40 Chicago Scientist Halo Cures, 2019
  • The James B. Nachman, MD Fellowship University of Chicago, 2018
  • Top Young Investigator Oral Abstract Advances in Neuroblastoma Research Congress, 2016

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Case Report Second Primary Rhabdomyosarcoma of the Uterine Cervix Presenting with Synchronous Ovarian Sertoli-Leydig Cell Tumor: An Illustrative Case of DICER1 Syndrome  
    Matthew Cowan, Melody Perpich, Mark A Applebaum, S Diane Yamada, Andrea D Olivas, Ricardo R Lastra, ScienceDirect
  • Evaluation of genetic predisposition for MYCN-amplified neuroblastoma  
    Hungate EA, Applebaum MA, Skol AD, Vaksman Z, Diamond M, McDaniel L, Volchenboum SL, Stranger BE, Diskin SJ, Maris JM, Onel K, Cohn SL, J Natl Cancer Inst, 1/1/2017

Books/Book Chapters

  • Transition from pediatric to adult medical care 
    Chapter: Utilization of technology in transition programs 
    Applebaum MA, Lawson EF, von Scheven EEditors: Wood D, Reiss JG, et al.Nova Science, New York, NY2012

Abstracts/Posters

  • Second Malignancies in Patients with Neuroblastoma
    Applebaum MA, International Neuroblastoma Conference, Houston, TX, 1/1/2017
  • Whole Genome Analysis of the Epigenetic Mark 5-Hydroxymethylcysteine Reveals Differential Profiles in Low-, Intermediate-, and High-Risk Neuroblastoma
    Applebaum MA, AACR Conference on Pediatric Cancer Research, Atlanta, GA, 1/1/2017
  • Evaluation of Hypoxia Adaptation in Neuroblastoma Identifies Reproducible Transcriptional and Phenotypic Ressponses
    Applebaum MA, ASCPT Annual Meeting, San Diego, CA, 1/1/2016

Other

Press Mentions

  • UChicago Medicine Highlights Research, Leadership, Clinical Advances at ASCO 2026
    UChicago Medicine Highlights Research, Leadership, Clinical Advances at ASCO 2026June 11th, 2026
  • Potential for More Targeted Treatments of Neuroblastoma Tumors
    Potential for More Targeted Treatments of Neuroblastoma TumorsJune 19th, 2017
  • Texting Improves Link Between Sick Teens and Doctors
    Texting Improves Link Between Sick Teens and DoctorsMay 20th, 2014

Grant Support

  • Liquid biopsy approaches to inform neuroblastoma prognosis and disease monitoringUNIVERSITY OF CHICAGO2022–2027
  • Elucidating transcription regulation by epigenetics in neuroblastomaNCI2018–2022
  • Paul Calabresi Career Development in Clinical Oncology AwardNCI2016–2018
  • Young Investigator AwardConquer Cancer Foundation of ASCO2016–2017
  • Training grant in Clinical Pharmacology and TherapeuticsNICHD2013–2016

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Mark Applebaum, Dr. Mark Applebaum, MD, Dr. M Applebaum